
How Migraine Is Treated After Diagnosis in the US: What a 154,353-Person Study Found
Nearly half of US adults newly diagnosed with migraine filled an opioid prescription within 3 years, while fewer than 1 in 10 started prevention with a…
What each study found, how strong the evidence is, and what it means for you. For the daily roundup of everything new, see Today in Migraine Science.

Nearly half of US adults newly diagnosed with migraine filled an opioid prescription within 3 years, while fewer than 1 in 10 started prevention with a…

A 2-year study of 3,017 people with migraine found pet owners, especially dog owners, had fewer and milder attacks. Here is what that means and why…

A meta-analysis of 19 studies and 3.6 million people linked migraine to modestly higher odds of glaucoma, a silent cause of vision loss. The link was…

A JAMA Neurology study of 7,579 pregnancies linked CGRP antibody injections in early pregnancy to a higher miscarriage rate. Propranolol showed no link, which matters for…

A survey of 12,612 people with migraine in six countries found nearly 1 in 4 used opioids for headache. Users reported more disability and four times…

A new Cephalalgia study paired a wrist-worn sensor with personalized machine learning and flagged pre-attack periods 2 to 12 hours before the headache started in most…

A 2026 review gathered every published report of hair loss on CGRP antibodies and gepants. The signal is consistent across the class, the hair loss is…

A meta-analysis of 53 real-world studies found about three in four people were still on an anti-CGRP therapy at one year. Most who stopped did so…

A 25-trial analysis ranked Excedrin-type combos and ibuprofen above gepants for 2-hour pain relief.

In 6,267 adults, both short and long sleep went with more headache days and higher disability.

Vaporized THC plus CBD beat placebo for acute attacks in the one randomized migraine trial.

Seven studies show vestibular rehab cuts dizziness handicap in vestibular migraine.

In 479 real-world patients, Botox cut chronic migraine by about 6 headache days a month.

Six trials and 3,453 people show how much atogepant cuts migraine days and which dose works best.

Across 22 studies, more screen time went with about 60% higher odds of migraine or headache.

A review of 8 trials graded the evidence for ginger in migraine as low or very low certainty.

In 189,000 Danes, starting semaglutide was followed by about 7% fewer triptan prescriptions.

In 1,000 people with migraine and a PFO, rivaroxaban beat metoprolol for prevention.